Tallantyre E - Search Results

1

The Impact of COVID-19 on the Employment of People With Multiple Sclerosis: A Multiple Methods Study.

De Dios Perez B, Pritchard C, Powers K, das Nair R, Evangelou N, Ford H, Tallantyre E, Dobson R, Radford K. De Dios Perez B, et al. Among authors: tallantyre e. Int J MS Care. 2024 Jul 8;26(Q3):174-186. doi: 10.7224/1537-2073.2023-049. eCollection 2024 May. Int J MS Care. 2024. PMID: 38979405 Free PMC article.

2

Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI.

Tallantyre EC, Brookes MJ, Dixon JE, Morgan PS, Evangelou N, Morris PG. Tallantyre EC, et al. Neurology. 2008 May 27;70(22):2076-8. doi: 10.1212/01.wnl.0000313377.49555.2e. Neurology. 2008. PMID: 18505982 No abstract available.

3

Spotlight on teriflunomide.

Tallantyre E, Evangelou N, Constantinescu CS. Tallantyre E, et al. Int MS J. 2008 Jun;15(2):62-8. Int MS J. 2008. PMID: 18782502 Review.

4

Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease.

Tallantyre EC, Bø L, Al-Rawashdeh O, Owens T, Polman CH, Lowe J, Evangelou N. Tallantyre EC, et al. Brain. 2009 May;132(Pt 5):1190-9. doi: 10.1093/brain/awp106. Brain. 2009. PMID: 19420101

5

A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions.

Tallantyre EC, Morgan PS, Dixon JE, Al-Radaideh A, Brookes MJ, Evangelou N, Morris PG. Tallantyre EC, et al. Invest Radiol. 2009 Sep;44(9):491-4. doi: 10.1097/RLI.0b013e3181b4c144. Invest Radiol. 2009. PMID: 19652606

6

Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis.

Tallantyre EC, Bø L, Al-Rawashdeh O, Owens T, Polman CH, Lowe JS, Evangelou N. Tallantyre EC, et al. Mult Scler. 2010 Apr;16(4):406-11. doi: 10.1177/1352458510364992. Epub 2010 Mar 9. Mult Scler. 2010. PMID: 20215480

7

3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions.

Tallantyre EC, Morgan PS, Dixon JE, Al-Radaideh A, Brookes MJ, Morris PG, Evangelou N. Tallantyre EC, et al. J Magn Reson Imaging. 2010 Oct;32(4):971-7. doi: 10.1002/jmri.22115. J Magn Reson Imaging. 2010. PMID: 20882628

8

Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions.

Tallantyre EC, Dixon JE, Donaldson I, Owens T, Morgan PS, Morris PG, Evangelou N. Tallantyre EC, et al. Neurology. 2011 Feb 8;76(6):534-9. doi: 10.1212/WNL.0b013e31820b7630. Neurology. 2011. PMID: 21300968 Free PMC article.

9

Focal multiple sclerosis lesions abound in 'normal appearing white matter'.

Mistry N, Tallantyre EC, Dixon JE, Galazis N, Jaspan T, Morgan PS, Morris P, Evangelou N. Mistry N, et al. Among authors: tallantyre ec. Mult Scler. 2011 Nov;17(11):1313-23. doi: 10.1177/1352458511415305. Epub 2011 Jul 25. Mult Scler. 2011. PMID: 21788249

10

Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brain.

Mistry N, Dixon J, Tallantyre E, Tench C, Abdel-Fahim R, Jaspan T, Morgan PS, Morris P, Evangelou N. Mistry N, et al. Among authors: tallantyre e. JAMA Neurol. 2013 May;70(5):623-8. doi: 10.1001/jamaneurol.2013.1405. JAMA Neurol. 2013. PMID: 23529352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters